Preventing 
cardiovascular

events with research

Personalised medicine for coronary heart disease

EU-funded CoroPrevention project aims to discover long-term behaviour changes and lifestyle improvements as well as medications needed by individual patients with coronary heart disease to prevent another cardiovascular event.

The project’s objective is to significantly reduce premature deaths and severe disabilities in patients with coronary heart disease in Europe. The CoroPrevention project studies 12,000 patients from six EU countries.

Read more

Cardiovascular diseases cost €210 billion a year

Cardiovascular disease (CVD) accounts for 47% of deaths in women and 39% of deaths in men worldwide. CVDs cost the EU more than €210 billion a year, a sum expected to escalate with an ageing population and the cost of novel therapies.

We estimate that the CoroPrevention programme will reduce the cardiovascular event rate by 25% in high-risk patients – with annual savings of tens of billions of euros to the EU.

Read more

Latest news & events

25 Mar 2022, 16:21
CoroPrevention at EAPC Congress 2022
We are proud to announce that CoroPrevention will be at the centre of symposium of the EAPC Congress 2022 taking place…
Read more
2 Nov 2021, 14:03
Interview with Dr. Sippy Kaur
Q1: Could you tell us a bit about yourself? I have a PhD in cancer genetics. During my postdoctoral research I have…
Read more
29 Apr 2020, 11:50
Using the Onnikka weight management program to meet European clinical practice guidelines
At the beginning of 2020, the EU kicked off the international CoroPrevention research project, which concentrates on the…
Read more